Skip to content

Influence of an Anterior Latarjet-type Abutment Operation on Scapular Dyskinesia and the Muscular Stabilization Mechanisms of the Scapula (DyScapLat)

Influence of an Anterior Latarjet-type Abutment Operation on Scapular Dyskinesia and the Muscular Stabilization Mechanisms of the Scapula (DyScapLat)

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05131126
Acronym
DyScapLat
Enrollment
50
Registered
2021-11-23
Start date
2019-05-22
Completion date
2023-05-22
Last updated
2021-11-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Latarjet, Scapular Dyskinesis

Brief summary

The aim of this study is to assess the influence of anterior abutment surgery using the Latarjet method on the kinematics of the scapula. The sub-objectives will be to show that Latarjet-type surgery does not lead to scapular dyskinesia and modification of muscle activity compared to a control group that has not undergone an operation.

Interventions

PROCEDURELatarjet method

This operation consists of fixing a bone graft

OTHERDifferent arms exercices

Perform 5 elevation movements in each of the elevation planes (sagittal, scapular and coronal) with the right and left arms * Perform 5 circumduction movements with the right and left arms * Maintain a weight of 1kg twice for 5 seconds with the arms at 90 ° of elevation.

Sponsors

European Clinical Trial Experts Network
CollaboratorOTHER
Ramsay Générale de Santé
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Patient Group: * Male between 18 and 40 years-old * Practice a regular sports activity before the injury (s) requiring surgery * Present the clinical criteria leading to anterior abutment surgery using the Latarjet method * Surgery performed by surgeons from the Jean-Mermoz Private Hospital (69008 Lyon) * Have followed a post-surgery self-rehabilitation program Control group: * Male between 18 and 40 years-old * Practice a regular sports activity Both group: oPatient having signed an informed consent o Subject affiliated or beneficiary of a social security scheme

Exclusion criteria

Patient group: * Have another shoulder pathology on the side of the operated limb or on the contralateral side * Present a constitutional hyper laxity * Have stiffness or recurrence of dislocation of the shoulder post-surgery * Have a body mass index greater than 30 kg / m² (to ensure sufficient accuracy to measure the movements of the scapula) * Wear a pacemaker or any other metal device (e.g. patch with metal material) * Present a contraindication to the use of measuring devices (intolerance to a weak electromagnetic field) Control group: * Present during the study or have presented in the past any musculoskeletal pathology in the right or left shoulder (WOSI or WORC score greater than 250). * Have a body mass index greater than 30 kg / m² (to ensure sufficient accuracy to measure the movements of the scapula) * Wear a pacemaker or any other metal device (e.g. patch with metal material) * Present a contraindication to the use of measuring devices (intolerance to a weak electromagnetic field) Both group : o Protected subject: adult under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision

Design outcomes

Primary

MeasureTime frameDescription
Difference in position of the scapula (tilt, rotation and bell) between the pre and post-test measured in the control group4 monthsFor electromyographic analysis, the signals will be filtered, smoothed and normalized to obtain a percentage of activation relative to that measured during submaximal voluntary contractions.

Countries

France

Contacts

Primary ContactJean-François Oudet
jf.oudet@ecten.eu0683346567
Backup ContactMarie-Hélène Barba
mh.barba@ecten.eu

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026